Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Qingdao technology bureau (13-1-3-34-nsh)
- Qingdao University
This publication has 28 references indexed in Scilit:
- Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral ToxicityPLOS Pathogens, 2013
- A Comparison of the Short-Term Effects of a Botulinum Toxin Type A and Triamcinolone Acetate Injection on Adhesive Capsulitis of the ShoulderAnnals of Rehabilitation Medicine, 2013
- Central origin of the antinociceptive action of botulinum toxin type APharmacology Biochemistry and Behavior, 2009
- Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of ArthritisPain Medicine, 2009
- European consensus table on the use of botulinum toxin type A in adult spasticityJournal of Rehabilitation Medicine, 2009
- The Role of TRPV1 in Different Subtypes of Dorsal Root Ganglion Neurons in Rat Chronic Inflammatory Nociception Induced by Complete Freund's AdjuvantMolecular Pain, 2008
- Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammationArthritis & Rheumatism, 2005
- Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor ActivityJournal of Biological Chemistry, 2004
- Calcitonin‐gene‐related‐peptide‐immunoreactive innervation of the rat head with emphasis on specialized sensory structuresJournal of Comparative Neurology, 1989
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980